The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer
The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
RAD51, a central player in the response to DNA damage, has been suspected to contribute to tumour resistance to therapy. A single-nucleotide polymorphism,
RAD51
135G>C, in the untranslated region of the
RAD51
gene elevates breast cancer risk among
BRCA2
carriers. In this study, it was investigated whether this polymorph...
Alternative Titles
Full title
The RAD51 135G>C polymorphism is related to the effect of adjuvant therapy in early breast cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_DiVA_org_liu_17954
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_DiVA_org_liu_17954
Other Identifiers
ISSN
0171-5216,1432-1335
E-ISSN
1432-1335
DOI
10.1007/s00432-014-1859-0
